Epidemiology and Management of Metastatic Breast Cancer

AstraZeneca

Status: Completed

Conditions: Breast Cancer Nos Metastatic Recurrent

Study type: Observational

Funder types: Industry

Identifiers

NCT01711502

NIS-ORO-XXX-2012/1

Details and patient eligibility

About

This is a multicenter, national, retrospective chart-review study that will be based on the collection of data from electronical or paper-based medical records with available data on female patients diagnosed with metastatic brest cancer . The main purpose of this study is to provide accurate, evidence based description on the incidence of progression of metastatic breast cancer and its clinical management.

Full description

Epidemiology and Therapeutic Management of Metastatic Breast Cancer in Romania: A retrospective cohort study

Enrollment: 128 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female aged 18 years and over Diagnosis of breast cancer according to ICD-10 diagnostic criteria with confirmed metastasis
• Confirmed diagnosis between 1st July 2010 - 30th June 2011
• Female patient managed for her disease at the same setting where final diagnosis of MBC was performed

Exclusion criteria

• History of concurrent or other primary malignancies (except curatively resected non-melanoma skin cancer or in situ cervical cancer)

Trial design

128 participants in 1 patient group

Female patients diagosed with metastatic breast cancer